Calliditas Therapeutics AB (publ) (CALT) Institutional Ownership $40.00 0.00 (0.00%) (As of 11/15/2024 ET) Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Calliditas Therapeutics AB (publ) (NASDAQ:CALT)CurrentInstitutional OwnershipPercentage2.83%Number ofInstitutional Buyers(last 12 months)2TotalInstitutional Inflows(last 12 months)$669.91KNumber ofInstitutional Sellers(last 12 months)0 Get CALT Insider Trade Alerts Want to know when executives and insiders are buying or selling Calliditas Therapeutics AB (publ) stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data CALT Institutional Buying and Selling by Quarter Ad Porter & CompanyThis company will win the AI race Rome wasn’t built in a day… But there is another lesser-known type of keystone, one that plays an equally critical role in supporting the most revolutionary technology the world’s ever seen… artificial intelligence. And without it, the entire AI industry would collapse. You must read this new presentation from Porter Stansberry. Calliditas Therapeutics AB (publ) Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails11/4/2024 Crossmark Global Holdings Inc.16,117$655K0.0%N/A0.054% 2/13/2024 Optiver Holding B.V.980$25K0.0%N/A0.003% 5/15/2023 Ironwood Investment Management LLC27,795$666K0.4%+5.6%0.093% 5/11/2023 Optiver Holding B.V.5,029$120K0.0%-54.9%0.017% 2/10/2023 Optiver Holding B.V.11,141$195K0.0%-11.8%0.037% 2/9/2023 HBK Sorce Advisory LLC90,000$104K0.0%+100.0%0.302% Get the Latest News and Ratings for CALT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Calliditas Therapeutics AB (publ) and its competitors with MarketBeat's FREE daily newsletter. 1/31/2023 Ironwood Investment Management LLC26,309$447K0.3%-8.5%0.088% 11/14/2022 Optiver Holding B.V.12,625$191K0.0%+1,304.3%0.043% 11/14/2022 HBK Sorce Advisory LLC45,000$50K0.0%N/A0.152% 5/10/2022 Ironwood Investment Management LLC28,762$551K0.3%+5.5%0.110% 2/10/2022 Ironwood Investment Management LLC27,267$675K0.3%-2.0%0.104% 11/12/2021 Ironwood Investment Management LLC27,836$602K0.3%+75.2%0.106% 8/27/2021Endurant Capital Management LP144,393$4.25M1.2%+1.5%0.552% 8/12/2021 Advisory Services Network LLC3,369$99K0.0%N/A0.013% 8/11/2021 Deutsche Bank AG71,531$2.11M0.0%+1.8%0.286% 7/31/2021NEXT Financial Group Inc4,458$131K0.0%N/A0.018% 5/19/2021 Hillhouse Capital Advisors LTD.944,716$26.10M0.3%-9.8%3.783% 5/18/2021 Millennium Management LLC15,570$430K0.0%-24.0%0.062% 5/18/2021 Tudor Investment Corp Et Al13,782$380K0.0%N/A0.055% 5/18/2021 Citadel Advisors LLC9,571$264K0.0%N/A0.038% 5/17/2021Endurant Capital Management LP142,323$3.92M1.0%N/A0.570% 2/17/2021Jane Street Group LLC7,557$256K0.0%-26.5%0.032% 2/13/2021 Hillhouse Capital Advisors LTD.1,047,687$35.61M0.3%+199.3%4.371% 12/9/2020 Pentwater Capital Management LP61,084$1.47M0.0%-7.4%0.255% 11/17/2020Jane Street Group LLC10,278$244K0.0%+13.8%0.043% 11/17/2020 Logos Global Management LP550,000$13.20M1.7%+83.3%2.295% 11/16/2020 Point72 Asset Management L.P.257,892$6.19M0.0%-42.7%1.076% 11/6/2020BlackRock Inc.1,191$29K0.0%N/A0.005% (Data available from 1/1/2016 forward) CALT Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of CALT shares? During the previous two years, the following institutional investors and hedge funds held shares of Calliditas Therapeutics AB (publ) shares: Ironwood Investment Management LLC ($666K), Crossmark Global Holdings Inc. ($655K), and HBK Sorce Advisory LLC ($104K), Optiver Holding B.V. ($25K).Learn more on CALT's institutional investors. What percentage of Calliditas Therapeutics AB (publ) stock is owned by institutional investors? 2.83% of Calliditas Therapeutics AB (publ) stock is owned by institutional investors. Learn more on CALT's institutional investor holdings. Which institutional investors have been buying Calliditas Therapeutics AB (publ) stock? The following institutional investors have purchased Calliditas Therapeutics AB (publ) stock in the last 24 months: HBK Sorce Advisory LLC ($45K), Crossmark Global Holdings Inc. ($16.12K), Ironwood Investment Management LLC ($1.49K), and Optiver Holding B.V. ($980.00). How much institutional buying is happening at Calliditas Therapeutics AB (publ)? Institutional investors have bought a total of 63,583 shares in the last 24 months. This purchase volume represents approximately $1.47M in transactions. Which Calliditas Therapeutics AB (publ) major shareholders have been selling company stock? The following institutional investors have sold Calliditas Therapeutics AB (publ) stock in the last 24 months: Optiver Holding B.V. ($7.60K), and Ironwood Investment Management LLC ($2.43K). How much institutional selling is happening at Calliditas Therapeutics AB (publ)? Institutional investors have sold a total of 10,029 shares in the last 24 months. This volume of shares sold represents approximately $213.09K in transactions. Related Companies Travere Therapeutics Major Shareholders Omeros Major Shareholders Enanta Pharmaceuticals Major Shareholders Biohaven Major Shareholders Crinetics Pharmaceuticals Major Shareholders BridgeBio Pharma Major Shareholders Ultragenyx Pharmaceutical Major Shareholders Immunovant Major Shareholders Organon & Co. Major Shareholders Rhythm Pharmaceuticals Major Shareholders This page (NASDAQ:CALT) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Calliditas Therapeutics AB (publ) Please log in to your account or sign up in order to add this asset to your watchlist. Share Calliditas Therapeutics AB (publ) With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CALT Stock Alerts